Medicim nominated as fast-growing company in the province of Antwerp 2019

On February 27, 2019, Medicim was nominated as Trends Gazelle 2019 in the category of medium-sized companies in the province of Antwerp (Belgium). Trends ranks companies based on growth numbers: growth in revenue, growth in personnel and growth in added value. This nomination recognizes Medicim as one of the fastest growing companies in the region.

We are proud to be nominated for the fifth time: 2014, 2016 (28), 2017 (27), 2018 (21), 2019 (11). Continued hard work of all employees, and continuous investment in innovation are key contributing factors to our success.

We are confident that with our new software suite DTX Studio, we are facing a bright future with continued growth. In this way, we create smiles on patients faces through our customers, the dental professionals. These smiles motivate us every day to enhance better patient care with our digital solutions.

Medicim – Innovative software solutions to create smiles

Medicim is a spin-off company from the Medical Image Computing research team of the University of Leuven (KU Leuven), founded in 2002. Our focus lies on creating innovative software solutions that make patients and dental professionals smile. Close cross-functional collaboration between clinicians, technicians and software experts makes this possible.

Today, Medicim is part of Danaher’s dental platform including brands like Nobel Biocare, KaVo Kerr and Ormco. While adhering to our initial mission to make medical image computing technology available to the dental community, we have reviewed our strategy, confirmed our key values, and updated our purpose, vision and mission.

We further accelerate the adoption of workflow-driven software solutions with our new DTX Studio suite. We enhance our teams with the best and passionate talent. We provide the best support and services to help our customers around the globe with their success. This results in broad growth options for our associates and great value creation for our shareholders.

A new big step forward, a new era for Medicim!